Studies in Hyp mice using this novel peptide confirmed that the inhibition of FGF23 signaling in kidney upregulates the expression of the sodium-phosphate cotransporters Npt2a and Npt2c, coupled with the alleviation of the observed hypophosphatemia (34). The gene discussed is FGF23; the disease is hypophosphatemia.